Clinical trial
A Modified Case Control Study to Identify Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate
NCT00890448 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Modified Case Control Study to Identify Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- May 31, 2010
- Enrollment
- 66 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
toxicity